Published :
Tables : 51
Figures : 43
Category : Healthcare
No. of Pages : 202
Report Code : HC-U3383
Arthropod-borne Viral Infections Testing Market Dynamics: The arboviral infections are caused by viruses spread by the bite of an arthropod like mosquito or tick. Instances of arboviruses are yellow fever, chikungunya, St. Louis encephalitis, dengue, eastern equine encephalitis, California encephalitis, zika, Western Nile and Powassan. There are over 130 types of arthropod borne viral infections that affect humans. People generally suffer with no symptoms or mild symptoms like skin rash, headache, etc. The arbovirus diagnostics is capable of detecting the antibodies that are produced by the immune system while responding to a specific arbovirus. The rising expenditure in public healthcare, increased prevalence of arbovirus diseases are some of the key factors responsible for the arthropod-borne viral infections testing market growth. Arthropod-borne Viral Infections Testing Market Segmentation: By Test Type • Molecular Tests • Cultural Tests • Immunoassays • Others By End User • Hospitals • Research Centers • Diagnostic Centers By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa The market is classified into test type, end user and region. The test type segment is fragmented into molecular tests, culture tests, immunoassays and others. The molecular test segment is predicted to hold the largest arthropod borne viral infections testing market share owing to its high ability and accuracy of diagnosing diseases within a short time span. The end user segment is diversified into hospitals, research centres, diagnostic laboratories and others. The hospital segment is anticipated to lead the market during the forecast period owing to advancements in the hospital infrastructure and the availability of skilled professionals. Regional Analysis: The North America region is expected to subjugate the market owing to the rising geriatric population, rising occurrence of arbovirus and a strong presence of key players in the region. Furthermore, the higher acceptance of diagnostic tests, increased expenditure on healthcare have boosted the market growth in this region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecast period and this can be attributed to the rising patient population, growing awareness regarding arbovirus diseases, improving healthcare infrastructure. Competitive Landscape: Some of the major market players associated are Abbott, Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, bioMerieux SA, Hologic Inc., MedMira Inc., QIAGEN, Roche Molecular Systems Inc., Danaher Corporation, Siemens Healthineers, Thermo Fisher Scientific Inc. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global arthropod-borne viral infections testing market by test type, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Arthropod-borne Viral Infections Testing Market Dynamics:
The arboviral infections are caused by viruses spread by the bite of an arthropod like mosquito or tick. Instances of arboviruses are yellow fever, chikungunya, St. Louis encephalitis, dengue, eastern equine encephalitis, California encephalitis, zika, Western Nile and Powassan. There are over 130 types of arthropod borne viral infections that affect humans. People generally suffer with no symptoms or mild symptoms like skin rash, headache, etc. The arbovirus diagnostics is capable of detecting the antibodies that are produced by the immune system while responding to a specific arbovirus. The rising expenditure in public healthcare, increased prevalence of arbovirus diseases are some of the key factors responsible for the arthropod-borne viral infections testing market growth.
Arthropod-borne Viral Infections Testing Market Segmentation:
By Test Type • Molecular Tests • Cultural Tests • Immunoassays • Others By End User • Hospitals • Research Centers • Diagnostic Centers By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa The market is classified into test type, end user and region. The test type segment is fragmented into molecular tests, culture tests, immunoassays and others. The molecular test segment is predicted to hold the largest arthropod borne viral infections testing market share owing to its high ability and accuracy of diagnosing diseases within a short time span. The end user segment is diversified into hospitals, research centres, diagnostic laboratories and others. The hospital segment is anticipated to lead the market during the forecast period owing to advancements in the hospital infrastructure and the availability of skilled professionals. Regional Analysis: The North America region is expected to subjugate the market owing to the rising geriatric population, rising occurrence of arbovirus and a strong presence of key players in the region. Furthermore, the higher acceptance of diagnostic tests, increased expenditure on healthcare have boosted the market growth in this region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecast period and this can be attributed to the rising patient population, growing awareness regarding arbovirus diseases, improving healthcare infrastructure.
Competitive Landscape: Some of the major market players associated are Abbott, Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, bioMerieux SA, Hologic Inc., MedMira Inc., QIAGEN, Roche Molecular Systems Inc., Danaher Corporation, Siemens Healthineers, Thermo Fisher Scientific Inc.
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the global arthropod-borne viral infections testing market by test type, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Arthropod-Borne Viral Infections Testing Market, By Test Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Molecular Tests 7.2 Culture Tests 7.3 Immunoassays 7.4 Others 8. Arthropod-Borne Viral Infections Testing Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Hospitals 8.2 Research Centers 8.3 Diagnostic Laboratories 8.4 Others 9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 9.2.1. U.S. 9.2.2. Canada 9.2.3. Mexico 9.2.4 Rest of North America 9.3 Market Size (USD Mn) Forecast for North America 2020-2027 10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 10.3.1. Brazil 10.3.2. Uruguay 10.3.3 Argentina 10.3.4. Rest of Latin America 10.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5 Switzerland 11.2.6. Spain 11.2.7. Russia 11.2.8. Poland 11.2.9. Rest of Western Europe 11.3 Market Size (US$ Mn) Forecast for North America 2020-2027 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1 Introduction 12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1 Japan 12.2.2 China 12.2.3 Singapore 12.2.4 Korea 12.2.5 India 12.2.6 Australia and New Zealand 12.2.7 ASEAN 12.2.8 Rest of Asia Pacific 12.3 Market Size (US$ Mn) Forecast for North America 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 UAE 13.2.2 South Africa 13.2.3 Egypt 13.2.4 Saudi Arabia 13.2.5 Rest of MEA 13.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1 Abbott 14.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2 Becton, Dickinson and Company 14.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3 Merck KGaA 14.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4 Bio-Rad Laboratories 14.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 bioMerieux SA 14.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Hologic Inc. 14.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7 MedMira Inc. 14.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8 QIAGEN N.V. 14.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9 Roche Molecular Systems Inc. 14.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10 Danaher Corporation 14.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 15 Impact of COVID-19 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16 Competitive Intelligence and Competitive Matrix 16.1 Competitive Intelligence 16.2 Competitive Matrix 17. Major Deals and Strategic Alliances Analysis 17.1 Joint ventures 17.2 Mergers and acquisitions 17.3 Licensing and partnerships 17.4 Technology Collaborations 17.5 Strategic Divestments 17.6 Market Entry Strategies 18. Relevant Case Studies and Latest News Updates 19. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
4. Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Industry Value Chain Analysis
4.4 Cost Analysis Breakdown
4.5 Technology Overview
4.6 Regulatory Framework on Country Level
4.6.1 Reimbursement Framework
4.6.2 Standards and Compliances
5. Market Overview
5.1 Market Dynamics
5.1.1 Market Driver Analysis
5.1.2 Market Restraint Analysis
5.1.3 Industry Challenges
6. Market Analysis tools
6.1 Industry Analysis - Porter’s
6.1.1 Supplier Power
6.1.2 Buyer Power
6.1.3 Substitution Threat
6.1.4 Threat from new entrants
6.1.5 Competitive Rivalry
6.2 Pestel Analysis
6.2.1 Political Landscape
6.2.2 Environmental Landscape
6.2.3 Social landscape
6.2.4 Technology landscape
6.2.5 Legal Landscape
7. Arthropod-Borne Viral Infections Testing Market, By Test Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
7.1 Molecular Tests
7.2 Culture Tests
7.3 Immunoassays
7.4 Others
8. Arthropod-Borne Viral Infections Testing Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
8.1 Hospitals
8.2 Research Centers
8.3 Diagnostic Laboratories
8.4 Others
9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
9.1. Introduction
9.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4 Rest of North America
9.3 Market Size (USD Mn) Forecast for North America 2020-2027
10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
10.3.1. Brazil
10.3.2. Uruguay
10.3.3 Argentina
10.3.4. Rest of Latin America
10.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
11.2.1. Germany
11.2.2. U.K
11.2.3. France
11.2.4. Italy
11.2.5 Switzerland
11.2.6. Spain
11.2.7. Russia
11.2.8. Poland
11.2.9. Rest of Western Europe
11.3 Market Size (US$ Mn) Forecast for North America 2020-2027
12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1 Introduction
12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
12.2.1 Japan
12.2.2 China
12.2.3 Singapore
12.2.4 Korea
12.2.5 India
12.2.6 Australia and New Zealand
12.2.7 ASEAN
12.2.8 Rest of Asia Pacific
12.3 Market Size (US$ Mn) Forecast for North America 2020-2027
13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1 Introduction
13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
13.2.1 UAE
13.2.2 South Africa
13.2.3 Egypt
13.2.4 Saudi Arabia
13.2.5 Rest of MEA
13.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
14.1 Abbott
14.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.2. Product Portfolio
14.1.3. SWOT Analysis
14.1.4. Financial Overview
14.1.5. Strategic Overview
14.2 Becton, Dickinson and Company
14.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2. Product Portfolio
14.2.3. SWOT Analysis
14.2.4. Financial Overview
14.2.5. Strategic Overview
14.3 Merck KGaA
14.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2. Product Portfolio
14.3.3. SWOT Analysis
14.3.4. Financial Overview
14.3.5. Strategic Overview
14.4 Bio-Rad Laboratories
14.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2. Product Portfolio
14.4.3. SWOT Analysis
14.4.4. Financial Overview
14.4.5. Strategic Overview
14.5 bioMerieux SA
14.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.2. Product Portfolio
14.5.3. SWOT Analysis
14.5.4. Financial Overview
14.5.5. Strategic Overview
14.6 Hologic Inc.
14.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.6.2. Product Portfolio
14.6.3. SWOT Analysis
14.6.4. Financial Overview
14.6.5. Strategic Overview
14.7 MedMira Inc.
14.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.7.2. Product Portfolio
14.7.3. SWOT Analysis
14.7.4. Financial Overview
14.7.5. Strategic Overview
14.8 QIAGEN N.V.
14.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.8.2. Product Portfolio
14.8.3. SWOT Analysis
14.8.4. Financial Overview
14.8.5. Strategic Overview
14.9 Roche Molecular Systems Inc.
14.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.9.2. Product Portfolio
14.9.3. SWOT Analysis
14.9.4. Financial Overview
14.9.5. Strategic Overview
14.10 Danaher Corporation
14.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.10.2. Product Portfolio
14.10.3. SWOT Analysis
14.10.4. Financial Overview
14.10.5. Strategic Overview
15 Impact of COVID-19
15.1. Positive influence on the healthcare industry
15.2. The financial disruption of the manufacturing sector
15.3. Impact of COVID-19 on emerging companies
15.4. Significant mandates in the healthcare regulations initiated by administrations
15.5. The overall economic slowdown of the developing and developed nations
16 Competitive Intelligence and Competitive Matrix
16.1 Competitive Intelligence
16.2 Competitive Matrix
17. Major Deals and Strategic Alliances Analysis
17.1 Joint ventures
17.2 Mergers and acquisitions
17.3 Licensing and partnerships
17.4 Technology Collaborations
17.5 Strategic Divestments
17.6 Market Entry Strategies
18. Relevant Case Studies and Latest News Updates
19. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics